Clinical Trials with VMO for Melanoma

Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.

Alan N. Houghton, David M. Mintzer, Carlos Cordon‐Cardo et al. · Proceedings of the National Academy of Sciences · 1985 · 566 citations · Full text

Medicine, Dermatology, Oncology +15

Human Malignant Melanoma.

Annals of Internal Medicine · 1980 · 306 citations

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

M S Mitchell, June Kan‐Mitchell, Raymond A. Kempf et al. · PubMed · 1988 · 237 citations

Medicine, Immunology, Oncology +16

Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2.

Reiko F. Irie, D L Morton · Proceedings of the National Academy of Sciences · 1986 · 221 citations

Medicine, Immunology, Oncology +17

Antiviral protection by virus-immune cytotoxic T cells: infected target cells are lysed before infectious virus progeny is assembled.

Rolf M. Zinkernagel, Alana Althage · The Journal of Experimental Medicine · 1977 · 158 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16